Joint replacement bundles saved $1K per patient

Bundled payments are helping lower overall healthcare costs, with joint replacement bundles saving about $1,000 per patient annually, according to a second annual report on the model from the Lewin Group.

The model, Comprehensive Care for Joint Replacement (CJR), was implemented mid-2016 by the Centers or Medicare and Medicaid Services Innovation Center (CMMI) and is part of CMS’ overall strategy to leverage alternative payment models (APMs) to provide higher quality care at a lower cost. The CJR model rewards participating hospitals for lowering costs for a 90-day episode of care and improving quality with better patient outcomes through care coordination with all providers. Conversely, hospitals are penalized for higher costs or poor care.

The report looked at the first two years of performance for the model, which was mandatory for nearly all hospitals in 67 geographic locations. Overall, the CJR model saved Medicare an estimated $17.4 million after reconciliation payment paid to participating hospitals were accounted for, according to the report, though other estimates range from a net loss of $41.2 million to savings of nearly $76 million. The savings estimate figures are so wide-ranging due to uncertainty around reduction in episode payments.

During the first two performance years, payments were $997 less for CJR episodes compared to a control group. The results are about 3.7% from CJR baseline payments, according to the report.

The findings from the Lewin Group echo other cost estimates. A study published in New England Journal of Medicine earlier this year found CJR episodes cost $812, or 3.1%, less.

The savings were mostly due to a shift away from high-cost care settings. For example, CJR patients were more likely to spend fewer days in a skilled nursing facility compared to control group patients and fewer patients from CJR hospitals were discharged to an inpatient rehab facility.

At the same time, quality of care was maintained, the report found, using readmission rate, emergency department visits and mortality as quality measurements.

The CJR model is among CMS APMs, but the agency has been slow to reveal new models since the Trump administration came into power. Still, CMS could put forth new APMS, but will most likely make them voluntary.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.